CLARKE LEADS LETTER TO REVLON DEMANDING ANSWERS FOLLOWING FINDINGS OF DANGEROUS CONTAMINANTS IN COSMETICS

FOR IMMEDIATE RELEASE:

September 28, 2026

MEDIA CONTACT:

e: [email protected]

c: 202.913.0126

WASHINGTON, D.C. - Representative Yvette D. Clarke (NY-09) led a letter signed by nine Members of Congress to CEO of Revlon Group Holdings LLC, Michelle Peluso, following the FDA's recent findings that the cosmetics company failed to adequately test products for the presence of contaminants - including cancer-causing chemicals and mold - putting the health of its customers at risk, particularly its Black customers who are disproportionately represented in the beauty and personal care market.

"Black consumers, specifically women and girls, occupy a significant space within the overall U.S. beauty landscape. In 2026, beauty spending among Black consumers reached $16.2 billion, representing a 9 percent increase from the previous year. Given their prevalence in your customer base, it is our serious concern that Black women and girls would be disproportionately exposed to carcinogenic chemicals in contaminated beauty products," wrote the Members. "Products that pose a risk to consumers have no place in our markets. Black women and girls should be able to use beauty and personal care products, including over-the-counter (OTC) drug products, without worrying about potential exposure to harmful chemicals."

The letter was signed by: Representatives Clarke, Carson, Crockett, DeLauro, Grijalva, Holmes Norton, Thanedar, Tlaib, and Wilson (FL).

Full text of the letter can be found HERE.

###